Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis

Extra‐abdominal desmoid‐type fibromatosis (DF) is a rare, locally aggressive neoplasm that is usually managed conservatively. When treatment is indicated, it typically involves surgical resection, possibly with adjuvant radiotherapy. The indications for postoperative radiotherapy and its effectiveness are unclear. The objective of this study was to estimate the effect of surgical resection margins and adjuvant radiotherapy on rates of recurrence of DF.

[1]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  M. Meyerson,et al.  Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis , 2015, Genes, chromosomes & cancer.

[3]  M. D. den Bakker,et al.  Time Trends in the Incidence and Treatment of Extra-Abdominal and Abdominal Aggressive Fibromatosis: A Population-Based Study , 2015, Annals of surgical oncology.

[4]  V. Koljonen,et al.  The desmoid tumour: Local control after surgical treatment , 2015, Journal of plastic surgery and hand surgery.

[5]  T. Stricker,et al.  Surgical Resection Margins in Desmoid-type Fibromatosis: A Critical Reassessment , 2014, The American journal of surgical pathology.

[6]  K. S. Hall,et al.  Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. Richards,et al.  Extra-abdominal desmoid fibromatosis--a sarcoma unit review of practice, long term recurrence rates and survival. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  S. Verma,et al.  A systematic review of active treatment options in patients with desmoid tumours. , 2014, Current oncology.

[9]  Z. Wang,et al.  Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution , 2014, Tumor Biology.

[10]  D. Biau,et al.  Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. , 2014, The Journal of bone and joint surgery. American volume.

[11]  H. Eich,et al.  Radiotherapy Is Effective for Desmoid Tumors (Aggressive Fibromatosis) - Long-Term Results of a German Multicenter Study , 2014, Oncology Research and Treatment.

[12]  C. Mussi,et al.  Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  C. Mussi,et al.  Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm-a position paper from the Italian and the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  S. Gwyther,et al.  Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  T. van Dalen,et al.  Local recurrence after surgery for primary extra‐abdominal desmoid‐type fibromatosis , 2013, The British journal of surgery.

[16]  M. Gonen,et al.  A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis , 2013, Annals of surgery.

[17]  B. Holzapfel,et al.  Surgical resection and radiation therapy of desmoid tumours of the extremities: results of a supra-regional tumour centre , 2013, International Orthopaedics.

[18]  B. Yeap,et al.  Desmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical Series , 2012, Annals of Surgical Oncology.

[19]  A. Testori,et al.  Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations , 2012, World Journal of Surgical Oncology.

[20]  Benjamin D. L. Li,et al.  Update on desmoid tumors. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  H. Järvinen,et al.  Family History, Surgery, and APC Mutation Are Risk Factors for Desmoid Tumors in Familial Adenomatous Polyposis: An International Cohort Study , 2011, Diseases of the colon and rectum.

[22]  J. Blay,et al.  Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[24]  C. Du,et al.  Prognostic factors for extra‐abdominal and abdominal wall desmoids: A 20‐year experience at a single institution , 2009, Journal of surgical oncology.

[25]  L. Mariani,et al.  Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment , 2009, Annals of Surgical Oncology.

[26]  M. Bertagnolli,et al.  Multimodality treatment of mesenteric desmoid tumours. , 2008, European journal of cancer.

[27]  A. Lazar,et al.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. , 2008, The American journal of pathology.

[28]  M. Ballo,et al.  Long-term outcomes for desmoid tumors treated with radiation therapy. , 2008, International journal of radiation oncology, biology, physics.

[29]  J. Blay,et al.  Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  M. Ballo,et al.  Optimizing treatment of desmoid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  B. Seifert,et al.  The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network , 2007, Radiation oncology.

[32]  Yih-Leong Chang,et al.  Desmoid tumor of the head and neck , 2006, Head & neck.

[33]  P. Krippl,et al.  Margins in extra‐abdominal desmoid tumors: A comparative analysis , 2004, Journal of surgical oncology.

[34]  L. Mariani,et al.  Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  K. Stelzer,et al.  The efficacy of radiotherapy as postoperative treatment for desmoid tumors. , 2001, International journal of radiation oncology, biology, physics.

[36]  Kogelnik Hd.  Surgery versus radiotherapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles , 2000 .

[37]  F. Bertoni,et al.  Extraabdominal Desmoid Tumor: A Study of 83 Cases , 2000, Clinical orthopaedics and related research.

[38]  Charles R. Thomas,et al.  Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors , 2000, Cancer.

[39]  D. Leung,et al.  Extremity and trunk desmoid tumors , 1999, Cancer.

[40]  J. Thomas,et al.  Aggressive Fibromatosis: Evidence for a Stable Phase , 1998, Sarcoma.

[41]  A. Botha,et al.  Desmoids in familial adenomatous polyposis , 1997, The British journal of surgery.

[42]  E. Saxén,et al.  The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. , 1982, American journal of clinical pathology.

[43]  S. Bonvalot,et al.  Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. , 2015, European journal of cancer.

[44]  P. Hohenberger,et al.  Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. , 2015, European journal of cancer.

[45]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[46]  M. J. W. Mrcs,et al.  Surgical Outcomes following Resection for Sporadic Abdominal Wall Fibromatosis , 2014, Annals of Surgical Oncology.

[47]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[48]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[49]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[50]  C. Beauchamp.  A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases , 2009 .

[51]  I. Blanco,et al.  [Familial adenomatous polyposis]. , 2006, Gastroenterologia y hepatologia.

[52]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[53]  M. Ballo,et al.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.